Your browser is no longer supported. Please, upgrade your browser.
ENDP Endo International plc daily Stock Chart
Endo International plc
Index- P/E- EPS (ttm)-4.27 Insider Own0.40% Shs Outstand219.21M Perf Week-9.87%
Market Cap1.56B Forward P/E2.93 EPS next Y2.43 Insider Trans-2.23% Shs Float201.74M Perf Month-18.44%
Income-956.10M PEG- EPS next Q0.43 Inst Own98.60% Short Float9.79% Perf Quarter-27.72%
Sales2.95B P/S0.53 EPS this Y24.90% Inst Trans-0.16% Short Ratio6.21 Perf Half Y-61.09%
Book/sh-2.22 P/B- EPS next Y12.64% ROA-9.70% Target Price14.17 Perf Year24.04%
Cash/sh5.24 P/C1.36 EPS next 5Y- ROE524.30% 52W Range5.41 - 18.50 Perf YTD-2.47%
Dividend- P/FCF8.49 EPS past 5Y-35.50% ROI-5.70% 52W High-61.51% Beta1.17
Dividend %- Quick Ratio1.00 Sales past 5Y6.80% Gross Margin44.60% 52W Low31.49% ATR0.38
Employees2910 Current Ratio1.20 Sales Q/Q2.30% Oper. Margin-14.50% RSI (14)28.73 Volatility5.62% 5.12%
OptionableYes Debt/Eq- EPS Q/Q16.00% Profit Margin-35.00% Rel Volume0.82 Prev Close7.15
ShortableYes LT Debt/Eq- EarningsFeb 28 BMO Payout- Avg Volume3.18M Price7.12
Recom2.60 SMA20-11.23% SMA50-21.00% SMA200-41.53% Volume2,612,168 Change-0.42%
Mar-20-19Initiated SunTrust Buy
Mar-05-19Downgrade SVB Leerink Outperform → Mkt Perform
Nov-09-18Upgrade Canaccord Genuity Hold → Buy $16 → $20
Sep-11-18Upgrade Goldman Sell → Neutral
Aug-13-18Upgrade RBC Capital Mkts Sector Perform → Outperform
Aug-09-18Reiterated Stifel Hold $10 → $17
Jun-27-18Upgrade Citigroup Neutral → Buy
Apr-04-18Downgrade Mizuho Buy → Neutral $12 → $7
Feb-28-18Downgrade Gabelli & Co Buy → Hold
Feb-14-18Initiated B. Riley FBR, Inc. Buy $10
Jan-03-18Reiterated Mizuho Buy $14 → $12
Jan-03-18Initiated Leerink Partners Outperform $12
Dec-12-17Initiated Guggenheim Neutral $8.50
Nov-10-17Reiterated RBC Capital Mkts Sector Perform $9 → $8
Sep-28-17Initiated Goldman Sell $7
Aug-09-17Reiterated RBC Capital Mkts Sector Perform $15 → $9
Jun-16-17Initiated Cantor Fitzgerald Neutral $12
Jun-09-17Downgrade Stifel Buy → Hold $22 → $15
May-25-17Reiterated Mizuho Buy $18 → $19
Feb-22-17Initiated Canaccord Genuity Hold $14
Apr-10-19 05:00PM  Endo to Announce First-Quarter 2019 Financial Results PR Newswire
Apr-09-19 02:04PM  When Will Endo International plc (NASDAQ:ENDP) Breakeven? Simply Wall St.
Apr-05-19 07:30AM  Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States PR Newswire
Apr-01-19 12:38PM  Drug companies that benefit from the war on opioid addiction Yahoo Finance
11:16AM  Drug companies that benefit from the war on opioid addiction Yahoo Finance Video
Mar-30-19 09:30AM  Why Is Endo (ENDP) Down 26.9% Since Last Earnings Report? Zacks
Mar-27-19 09:11PM  Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding Senior Notes PR Newswire
Mar-19-19 02:26PM  Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse Zacks
07:30AM  Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery PR Newswire
Mar-15-19 10:23AM  BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up Zacks
Mar-14-19 08:06PM  Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes PR Newswire
08:06PM  Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations PR Newswire
12:01PM  Endo Finance Co. -- Moody's downgrades Endo's secured debt to Ba3, unsecured notes to Caa1; B2 CFR affirmed Moody's
11:01AM  Insys Plunges on Auditor's Concern About Insufficient Funds Zacks
07:54AM  Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion Aggregate Purchase Price of its Outstanding Senior Notes PR Newswire
07:51AM  Endo International plc Announces Proposed Private Offering Of Senior Secured Notes PR Newswire
Mar-12-19 09:35AM  Is Endo International (ENDP) a Great Stock for Value Investors? Zacks
Mar-11-19 01:13PM  Opioid litigation concerns weigh on pharmaceutical loan borrowers Reuters
Mar-08-19 08:56AM  Endo (ENDP) Soars: Stock Adds 6% in Session Zacks
06:00AM  State Pensions Fought Guns and Tobacco. Why Arent They Divesting From Opioids? Bloomberg
Mar-07-19 07:35AM  Report: Exploring Fundamental Drivers Behind Procter & Gamble, Consolidated Edison, Lennar, Endo International plc, Box, and FRONT YARD RESIDENTIAL CORP New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +5.96%
Mar-05-19 04:36PM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks -6.54%
11:12AM  FDA ruling on compounding goes Endo's way American City Business Journals
Mar-04-19 12:45PM  Endo International plc (NASDAQ:ENDP) Insiders Have Been Selling Simply Wall St. -16.99%
08:39AM  Implied Volatility Surging for Endo (ENDP) Stock Options Zacks
08:00AM  Endo to Participate at Cowen & Company 39th Annual Healthcare Conference PR Newswire
Mar-01-19 06:04PM  Endo gains on favorable FDA drug compounding decision Reuters
03:27PM  Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List PR Newswire
02:20PM  Endo (ENDP) Q4 Earnings & Revenues Beat Estimates, Shares Up Zacks
07:30AM  Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting PR Newswire
06:46AM  Edited Transcript of ENDP earnings conference call or presentation 28-Feb-19 12:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 11:42AM  Endo International plc (ENDP) Q4 2018 Earnings Conference Call Transcript Motley Fool +6.29%
06:30AM  Endo Reports Fourth-Quarter And Full Year 2018 Financial Results PR Newswire
Feb-27-19 05:15PM  Endo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac Limited PR Newswire
Feb-22-19 07:30AM  Paladin Labs Inc. Announces Approval of Envarsus PA (tacrolimus prolonged-release tablets) in Canada CNW Group
Feb-21-19 10:31AM  Earnings Preview: Endo International (ENDP) Q4 Earnings Expected to Decline Zacks
Feb-07-19 12:59PM  FDA files motion to delay Endo litigation, again American City Business Journals
08:00AM  Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations PR Newswire
Jan-28-19 08:00AM  Today's Research Reports on Trending Tickers: OPKO Health and Endo International ACCESSWIRE
Jan-25-19 05:22PM  Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results PR Newswire
Jan-08-19 11:34AM  Albany region cities sue pharmaceutical companies over opioid epidemic American City Business Journals
Jan-02-19 11:25AM  Government shutdown puts Endo-FDA lawsuit in limbo American City Business Journals +5.62%
06:58AM  Heron Gains on Priority Review Designation for Pain Drug Zacks
Dec-31-18 08:52AM  Options Traders Expect Huge Moves in Endo (ENDP) Stock Zacks
07:30AM  Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations PR Newswire
Dec-19-18 07:30AM  Endo to Participate at J.P. Morgan Healthcare Conference PR Newswire -5.11%
Dec-18-18 11:40AM  Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets GlobeNewswire
Dec-16-18 07:10AM  Do Hedge Funds Love Endo International plc (ENDP)? Miller Value offer its opinion Insider Monkey
Dec-14-18 05:01PM  Endo International Drops Ahead Of '60 Minutes' Opioid Segment Benzinga -8.53%
03:55PM  Endo International plc (ENDP) Investigated For Violations of Federal Securities Laws by Block & Leviton LLP ACCESSWIRE
03:20PM  Endo International shares fall 8 percent on report of 'shocking' data on opioid distribution CNBC
Dec-12-18 07:54AM  FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller Reuters
Dec-11-18 09:23AM  Generic Drugmakers Down on Allegations of Price Fixing Zacks
Dec-08-18 09:30AM  Why Is Endo (ENDP) Down 12.3% Since Last Earnings Report? Zacks
Dec-05-18 02:17AM  Edited Transcript of ENDP earnings conference call or presentation 8-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
Dec-04-18 08:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Crocs, Ericsson, AAC, Coty, Tutor Perini, and Endo International plc New Research Emphasizes Economic Growth GlobeNewswire
Nov-28-18 04:34PM  Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference PR Newswire
Nov-26-18 12:55PM  Endo to Participate at Piper Jaffray Global Healthcare Conference PR Newswire -7.75%
Nov-20-18 05:49PM  Bill Miller Sees a Buying Opportunity
Nov-15-18 02:15PM  Managers Of This Fund Like The Outlook For Small-Cap Stocks Investor's Business Daily
Nov-13-18 12:51PM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
Nov-12-18 09:25AM  BioDelivery (BDSI) Q3 Earnings Beat, Sales In Line, Stock Up Zacks
Nov-09-18 03:28PM  Endo (ENDP) Stock Declines Despite Q3 Earnings & Revenue Beat Zacks
Nov-08-18 04:16PM  Endo Plans For Cellulite Drug In 2020 Here's Why Investors Balked Investor's Business Daily -17.72%
12:51PM  Here's Why Endo International Fell as Much as 18.9% Today Motley Fool
12:03PM  Endo International plc (ENDP) Q3 2018 Earnings Conference Call Transcript Motley Fool
09:10AM  Endo targets 2020 for launch of cellulite treatment Reuters
08:30AM  Endo International (ENDP) Q3 Earnings and Revenues Surpass Estimates Zacks
08:25AM  Endo: 3Q Earnings Snapshot Associated Press
07:28AM  Endo stock rises 6% after Q3 beats and upbeat 2018 guidance MarketWatch
07:00AM  Endo Reports Third-Quarter 2018 Financial Results PR Newswire
Nov-07-18 01:30PM  Q3 Earnings Preview For Endo Benzinga -6.48%
10:57AM  Endo posts positive results from experimental cellulite treatment American City Business Journals
07:30AM  Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite PR Newswire
Nov-06-18 10:31AM  What's in the Cards for BioSpecifics (BSTC) in Q3 Earnings? Zacks
Nov-05-18 05:32PM  Endo (ENDP) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-29-18 04:17PM  Knock Offs Loom For J&J's Blockbuster Why An Analyst Is Still Bullish Investor's Business Daily
08:44AM  Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)? Zacks
Oct-26-18 08:25AM  Recent Analysis Shows Supernus Pharmaceuticals, GDS HOLDINGS, Golden Ocean Group, Golar LNG, Endo International plc, and 51job Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Oct-23-18 08:00AM  Today's Research Reports on Trending Tickers: AbbVie and Endo International ACCESSWIRE
Oct-19-18 08:00AM  Today's Research Reports on Trending Tickers: Endo International and Amarin ACCESSWIRE
Oct-12-18 10:29AM  Rigel (RIGL) Gets EMA Acceptance for Thrombocytopenia Drug Zacks
Oct-11-18 07:30AM  Endo Presents Data on the Perception and Measurement of Cellulite Severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting PR Newswire
Oct-09-18 01:04PM  Opioid antidote inventor: We're in the 'next phase of this opioid crisis' Yahoo Finance
Oct-01-18 11:38AM  Endo Recalls 2 Lots of Robaxin Tablets Due to Labeling Error Zacks
Sep-28-18 02:45PM  Endo to Announce Third-Quarter 2018 Financial Results PR Newswire
11:59AM  [$$] Endo Recalls Robaxin Tablets Due to Dosing Error The Wall Street Journal
09:59AM  Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead Zacks
09:30AM  Has Endo International plc (ENDP) Outpaced Other Medical Stocks This Year? Zacks
08:32AM  Today's Research Reports on Trending Tickers: TherapeuticsMD and Endo International ACCESSWIRE
08:30AM  Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label PR Newswire
Sep-27-18 08:10AM  Recent Analysis Shows Golar LNG, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, Oracle, Ross Stores, Mellanox Technologies, and Endo International plc Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-24-18 12:11PM  Endo once more agrees to delay FDA litigation American City Business Journals
11:40AM  Endo puts Vasostrict case against U.S. FDA on hold Reuters
06:23AM  Endo puts Vasostrict case against U.S. FDA on hold Reuters
06:00AM  Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End PR Newswire
Sep-18-18 09:35AM  Is Endo International (ENDP) a Great Stock for Value Investors? Zacks
Sep-17-18 08:55AM  The Zacks Analyst Blog Highlights: Ingersoll-Rand, Endo International, Glanbia and Smurfit Kappa Group Zacks
Sep-14-18 10:59AM  5 Problematic Stocks Francis Chou Dared To Buy Insider Monkey
08:03AM  Irish Economy Rebounds in Q2: 4 Great Picks Zacks
Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. Its U.S. Branded - Specialty & Established Pharmaceuticals segment provides branded prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain, and orthopedics. This segment offers XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL Nasal Spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN Gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; FORTESTA Gel for men suffering from hypogonadism; EDEX to treat erectile dysfunction; and TESTIM for TRT in conditions associated with a deficiency or absence of endogenous testosterone. The company's U.S. Branded - Sterile Injectables segment offers branded sterile injectable products, such as VASOSTRICT, ADRENALIN, and APLISOL; and generic sterile injectable products. Its U.S. Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. It sells its branded pharmaceuticals and generics directly to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. The company was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MONTAGUE WILLIAM PDirectorDec 10Sale11.4110,000114,10064,888Dec 10 04:07 PM
Hutson Nancy JDirectorNov 15Sale12.8310,000128,30049,970Nov 16 04:03 PM
KIMMEL ROGER HDirectorAug 14Sale15.9014,000222,600120,000Aug 15 04:22 PM
KIMMEL ROGER HDirectorAug 14Sale15.9012,074191,977145,277Aug 15 04:22 PM